Emerging Data on Iron Management: Clinical Implications
ASN Renal Week, October, 2004
Welcome, Introduction and Program Overview
Dr. Allen R. Nissenson:
I had a series of about 4 or 5 slides to show you to introduce the topic, which apparently did not make into the slide package since Dr. Coyne's slides are up there, but I will give you just this brief introduction, which is to say that there are a whole variety of issues that are currently unresolved regarding iron. Clearly, when we first decided to do this, it was sort of hard to think about what is new and unique in iron therapy, but it turns out there are a still a lot of important unanswered questions related to iron, and we can only handle a small number of these.
We thought we would focus on, First, a presentation by Dr. Coyne who is going to discuss current data on IV iron therapy and the appropriate use of IV iron in this population, then presentation by Brad Warady on the use of parenteral irons in pediatric patients, which is an area that is increasingly important with the growing population of pediatric patients on hemodialysis.Thirdly, we will have a presentation by Dr. Kalantar-Zadeh on the relationship between iron stores and morbidity, and some very interesting data in that regard.
Then finally I am going to close the formal part of the program talking about assessment of iron stores, some information you are already familiar with the pluses and minuses of TSAT and ferritin, but then going to some other information about newer tests of iron status, where that stands, where we might go with this in the future, and then we will try to leave a few minutes for questions and answers.
I prefer to have the questions and answers at the end for the panel rather than after each talk.
TO GO TO FIRST TALK by Daniel Coyne, MD CLICK HERE